Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise ...

A new study suggests that the long-term antidepressant effects of psychedelics may be driven by persistent changes in how ...

In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine. This may suggest that psilocybin's ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with ...

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, its ...

Two-thirds of participants in a small-scale clinical trial said they were in complete remission from depression five years later Interviews suggest the treatment helped patients see their depression ...

(The Center Square) – Mental health care providers are rediscovering new uses for old medicines. Recent findings demonstrating the efficacy of psilocybin, the active ingredient in magic mushrooms, ...

Psilocybin has captured attention for its potential to ease depression and anxiety. But new findings from the University of California (UC), Davis, caution that psilocybin may not be a ...

Researchers have developed a new model to study the antidepressant and anti-anxiety effects of psilocybin in mice.